We have examined the applicability of the Hamilton Anxiety Scale (HAS) and our Melancholia Scale (MES) on a group of patients suffering from cardiac disease. They were assessed before surgery and again 1, 3, and 6 months after the operation. The results showed that the median for this group of patients even preoperatively was below the cut-off scores for both rating scales with a monotonous fall in score on the follow-ups. Item analysis showed that it was the psychic or cognitive symptoms of the HAS rather than the somatic symptoms of anxiety that explained the score variation. On the MES it was symptoms like depressed mood, psychic anxiety, pains, emotional and intellectual retardation rather than symptoms of guilt, motor retardation or suicidal impulses that were present. From both scales a total of 10 items emerged which were considered to measure generalized anxiety (Generalized Anxiety Scale). When the patients were classified into groups by a global assessment according to their ability to verbalize preoperative anxiety it was found that patients who were less able to verbalize had the lowest rating scale score. It was argued that preoperative anxiety is an introspective perception of fluctuating somatic manifestations of anxiety, whereas the rating scale procedure focuses on the persistent or cognitive part of anxiety which mostly is retrospectively perceived.

This content is only available via PDF.
© 1984 S. Karger AG, Basel
1984
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.